Press releasePRNewswire
Icecure Medical
ICCM · NASDAQ
$1.01+$0.01 (+1.00%)TodayMarket closed ·
Prev close $1.00
Latest news
- Press releasePRNewswire
IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026
- Press releasePRNewswire
IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site
- News
Full Transcript: Icecure Medical Q2 2026 Earnings Call
- Press releasePRNewswire
IceCure Medical Receives Regulatory Approval to Market ProSense® in China
- Press releasePRNewswire
IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands
- Press releasePRNewswire
West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation
- Press releasePRNewswire
IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation
- Press releasePRNewswire
IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releasePRNewswire
IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment
- Press releasePRNewswire
IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026
- Press releasePRNewswire
IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®
- Press releasePRNewswire
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
- Press releasePRNewswire
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
- Press releasePRNewswire
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- NewsVandana Singh
What's Going On With IceCure Medical Stock On Friday?
- Press releasePRNewswire
IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releasePRNewswire
IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer
- NewsAvi Kapoor
Why Smith & Wesson Brands Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
- NewsShivdeep Dhaliwal
Smartbird, Nebius Group, IceCure Medical, Robinhood And Meta: Why These 5 Stocks Are On Investors' Radars Today
- Press releasePRNewswire
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor
- NewsEvette Mitkov
IceCure Stock Surges After 70% ProSense Install Increase
- NewsAvi Kapoor
Crude Oil Edges Higher; US Retail Sales Top Estimates
- Press releaseGlobe Newswire
Biotech's New Frontier: Companies Breaking Through Medicine's Toughest Barriers
- NewsAvi Kapoor
US Stocks Edge Higher; CarMax Posts Upbeat Earnings
- Press releasePRNewswire
IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance
- NewsAvi Kapoor
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- Press releasePRNewswire
IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releasePRNewswire
IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked
- Press releasePRNewswire
IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
- News
Earnings Scheduled For May 12, 2026
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.